Market Research Report

U.S. Meniscus Treatment Market Research Report: Forecast (2025-2030)

U.S. Meniscus Treatment Market Report By Product Type (Meniscectomy Devices, Meniscus Repair Devices, Meniscus Replacement (Allograft/Implant), Meniscus Scaffold, Others (e.g., Sut...ures, Fixation Devices)), By Procedure (Arthroscopic Partial Meniscectomy, Meniscus Repair (Inside-Out, Outside-In, All-Inside Techniques), Meniscus Transplantation, Others), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Orthopedic Clinics, Others (Sports Medicine Centers, Academic Institutes)), By Distribution Channel (Direct Sales, Distributors/Wholesalers, Online Sales, Others) and others Read more

  • Healthcare
  • Jun 2025
  • Pages 181
  • Report Format: PDF, Excel, PPT

Get Actionable Insights for Smarter Decisions: Regional and country reports in one place pick a location for insights and Trends.

Market Definition

Meniscus refers to a C-shaped cartilage structure present inside the knee. Each knee contains two menisci, called medial and lateral. Their function is to absorb shocks, maintain stability, and protect our joints. Meniscus treatment refers to the medical care and healing procedures for the injuries, wear and tears to the meniscus.

Market Insights & Analysis: U.S. Meniscus Treatment Market (2025-30):

The U.S. Meniscus Treatment Market size was valued at around USD245.87 million in 2024 and is projected to reach USD329.49 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 5% during the forecast period, i.e., 2025-30. The U.S. Meniscus Treatment Market is significantly growing due to several factors, including the growing incidence of meniscal injuries while performing sporting activities, the rising aging population in the country, the government support, the heavy funding in the research and development programs to identify better meniscus treatments, and the adoption of advanced technologies in minimally invasive and robotic-assisted meniscus treatment, etc. One of the major factors is the rapidly rising aging population in the country. This population is highly prone to meniscus tears and injuries due to reduced elasticity and collagen fibers, and weakened muscles in older individuals, thus increasing the market growth.

Report Coverage Details
Historical Years 2020–23
Forecast Years 2025–30
Market Value in 2024 USD 245.87 million
Market Value by 2030 USD 329.49 million
CAGR (2025–30) 5%
Top Key Players Smith+Nephew plc, Arthrex, Inc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Johnson & Johnson (DePuy Synthes), ConMed Corporation, Medtronic plc, RTI Surgical Holdings, Inc., Bioventus Inc., others,
Key Report Highlights
  • Market Dimensions & Projections
  • Pricing Evaluation
  • Recent Strategic Moves by Companies
  • Primary Stakeholders
  • Import/Export Trend Analysis
  • Competitive Landscape Assessment
  • Emerging Opportunities
  • Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Additionally, the US government is actively supporting the research and development studies related to the identification of advanced and cost-effective treatment procedures for meniscal injuries, contributing to the potential market growth. Many universities and research institutions are heavily investing in clinical trials and procedures to increase the efficiency of the treatment for the meniscus. Moreover, the adoption of the latest innovations, including minimally invasive and robotic-assisted surgeries for meniscus treatments, is increasing the market growth, as these techniques have improved the procedures enabled with high automation and the incorporation of Artificial Intelligence. However, the market is facing high treatment costs and a shortage of skilled laborers to operate the advanced medical devices for the meniscus treatment, thus hindering the market growth.

U.S. Meniscus Treatment Market Driver:

Rising Incidence of Meniscal Injuries – The market is driven by the growing cases of meniscal injuries in the United States, especially in the field of outdoor sports. For instance, in 2024, over 246 million US citizens were active participants in sports, accounting for about 80% of the US population. This huge fraction of individuals is increasing the risk of meniscal injuries while playing. Out of 100,000 participants, almost 60 are meniscal tear cases, which translates to approximately 12% of the individuals facing meniscal injuries each year in the country.

Additionally, the country is witnessing a rapid surge in the aging population, which is further increasing the market growth, as older people gradually lose muscle strength, collagen fibers, and elasticity over time. For instance, as of 2025, over 59 million Americans are aged 65 years, contributing to approximately 18% of the US population. It is further projected to increase and reach up to 20% by the end of 2030. 30-40% of the geriatric population experiences a meniscal tear in the United States, increasing market growth.

U.S. Meniscus Treatment Market Opportunity:

Significant Funding in Orthopedic Research – The US government is significantly investing in orthopaedic research and development programs and contributing to the potential market growth. For instance, the Advanced Research Projects Agency for Health (ARPA-H) (2024) allocated about USD38 million to Columbia University researchers to develop a novel tissue regeneration treatment, including living knee replacements using human stem cells. Similarly, the National Institute of Health has been heavily investing in research programs related to meniscus repair.

Additionally, the Military Operational Medicine Research Program (MOMRP) under the Department of Defense allocated nearly USD2 million to support the studies and trials for musculoskeletal injuries, including meniscus recovery. Moreover, additional grants such as NSF joint grants, NIH clinical observation studies, are significantly allocating funds in the research related to meniscus treatments, thus contributing to the further market growth.


U.S. meniscus treatment market stats and Growth Charts

 

U.S. Meniscus Treatment Market Challenge:

High Treatment Cost & Shortage of Skilled Labors – The market is facing a high treatment cost challenge as these procedures involve advanced techniques such as arthroscopy, biologics, and minimally invasive procedures. For instance, per procedure can cost more than USD10,000. Additionally, the medical devices and the equipment used in the meniscus treatment procedures are also expensive, increasing the overall cost. For instance, a single unit of the fixation devices and suture anchors used in this treatment exceeds USD6,000. Similarly, a single biologic stem cell injection can cost around USD5,000. These are putting a financial barrier to a large fraction of the US population.

Moreover, currently, the United States is experiencing a scarcity of trained professionals and highly skilled orthopaedic surgeons in the country, and the demand for them is continuously rising. As of 2025, the country lacks about 7,000 orthopaedic surgeons. Treatments done by inexperienced surgeons cause surgical errors, which further lead to the high revision rates and increased costs, thus restraining the market growth.

U.S. Meniscus Treatment Market Trend:

Minimally Invasive & Robotic-Assisted Surgical Treatments Gaining Traction – The market dynamics are changing due to the discovery of minimally invasive and robotic-assisted surgical treatments for meniscus injuries in the United States. These procedures provide faster treatments & recovery rates and reduce long hospital stays over traditional treatments. Additionally, these treatments require small incisions to the body as compared to conventional open-heart surgeries and reduced blood losses, and provide high automation & precision in the treatment.

Several manufacturing companies, such as Smith+Nephew, Zimmer Biomet, etc., are actively manufacturing the advanced treatment medical devices for performing the surgeries of the meniscus, thus contributing to the market growth. For instance, Smith+Nephew (2024) launched a CORI System with AI features and robotic technologies for performing knee replacement procedures, including meniscus repairs. Similarly, Zimmer Biomet (2024) introduced the ROSA Knee system with continuously evolving robotic-assisted features for effective meniscus treatment. Therefore, all these advancements are expected to generate new growth potentials for the market players; as a result, the overall market size and volume are expected to rise sharply during the forecast period.

U.S. Meniscus Treatment Market (2025-30): Segmentation Analysis

The U.S. Meniscus Treatment Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for the period 2025–2030 at the national level. Based on the analysis, the market has been further classified as:

Based on Product Type:

  • Meniscectomy Devices
  • Meniscus Repair Devices
  • Meniscus Replacement (Allograft/Implant)
  • Meniscus Scaffold
  • Others (e.g., Sutures, Fixation Devices)

Out of these, the meniscus repair devices are the leading segment in this market and hold the largest market share of more than 40%. The growth is driven by the high preference of the patients to repair the meniscus over surgically removing it entirely, which is called meniscectomy. It is associated with a low risk of osteoarthritis, thus highly preferred by the patients. Over 5,00,000 meniscus repair surgeries have been performed in the US in the year of 2023, which led to more than 2,70,000 devices being sold in that year, and generated over USD135 million of revenue.

Additionally, many insurers are providing better insurance policies for meniscus repair surgeries in the country, which has attracted patients to opt for repair surgeries rather than removal surgeries, such as Meniscectomy. These factors are contributing to the dominance of these devices in the U.S. Meniscus Treatment Market.

Based on End-User:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Orthopaedic Clinics
  • Others (Sports Medicine Centers, Academic Institutes)

Among these, the hospitals segment holds the largest market share of about 35%. Hospitals provide a well-established infrastructure for performing surgical procedures in large-scale settings through the installation of big, advanced devices. These injuries cannot be treated without highly efficient surgeries, thus contributing to the dominance of hospitals in this market. Many hospitals are proactively using these procedures and increasing the market’s growth.

Additionally, the dominance is due to the analysis of a large volume of patients in a smaller period, which is contributing to the dominance of hospitals in this market. In 2020, more than 2,00,000 meniscus surgeries were performed in the US hospitals alone. Such a huge number of surgeries in hospitals is showing the dominance of these in this market. Moreover, the financial and governmental support from the country is significantly growing the market. These factors are driving the growth of the US Meniscus Treatment market.

U.S. Meniscus Treatment Industry Recent Development:

  • 2024: ConMed Corporation launched the GENESYS Matryx system, an all-inside meniscal repair device designed for simplicity and strong fixation.
  • 2024: Medtronic plc has entered the soft tissue repair market with new suture anchor systems and biologic augmentation products, aiming to support meniscal repair as part of its broader sports medicine strategy.

Gain a Competitive Edge with Our U.S. Meniscus Treatment Market Report

  1. U.S. Meniscus Treatment Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
  2. This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
  3. U.S. Meniscus Treatment Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Frequently Asked Questions

   A. The U.S. Meniscus Treatment Market is expected to grow at a compound annual growth rate (CAGR) of around 5% over the forecast period.

   A. The U.S. Meniscus Treatment Market size was valued at around USD245.87 million in 2024 and is projected to reach USD329.49 million by 2030.

   A. Rising incidence of meniscal injuries is expected to drive the U.S. Meniscus Treatment Market during 2025-30.

   A. Smith+Nephew plc, Arthrex, Inc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Johnson & Johnson (DePuy Synthes), ConMed Corporation, Medtronic plc, RTI Surgical Holdings, Inc., Bioventus Inc., and Others are the top companies in the U.S. Meniscus Treatment Market.

   A. Meniscus repair devices held the largest share of the U.S. Meniscus Treatment Market

   A. Minimally invasive and robotic-assisted surgical treatments are the key trends shaping the growth of the U.S. Meniscus Treatment Market.

   A. Significant funding in orthopedic research is one of the growth opportunities driving the U.S. Meniscus Treatment Market.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
    4. Executive Summary
  3. U.S. Meniscus Treatment Market Policies, Regulations, and Product Standards
  4. U.S. Meniscus Treatment Market Supply Chain Analysis
  5. U.S. Meniscus Treatment Market Trends & Developments
  6. U.S. Meniscus Treatment Market Dynamics
    1. Growth Drivers
    2. Challenges
  7. U.S. Meniscus Treatment Market Hotspot & Opportunities
  8. U.S. Meniscus Treatment Market Outlook, 2025-2030
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Procedures)
      3. Market Share & Outlook
        1. By Product Type
          1. Meniscectomy Devices – Market Size & Forecast 2025-2030, USD Million
          2. Meniscus Repair Devices – Market Size & Forecast 2025-2030, USD Million
          3. Meniscus Replacement (Allograft/Implant) – Market Size & Forecast 2025-2030, USD Million
          4. Meniscus Scaffold – Market Size & Forecast 2025-2030, USD Million
          5. Others (e.g., Sutures, Fixation Devices) – Market Size & Forecast 2025-2030, USD Million
        2. By Procedure
          1. Arthroscopic Partial Meniscectomy – Market Size & Forecast 2025-2030, USD Million
          2. Meniscus Repair (Inside-Out, Outside-In, All-Inside Techniques) – Market Size & Forecast 2025-2030, USD Million
          3. Meniscus Transplantation – Market Size & Forecast 2025-2030, USD Million
          4. Others – Market Size & Forecast 2025-2030, USD Million
        3. By End-User
          1. Hospitals – Market Size & Forecast 2025-2030, USD Million
          2. Ambulatory Surgical Centers (ASCs) – Market Size & Forecast 2025-2030, USD Million
          3. Orthopedic Clinics – Market Size & Forecast 2025-2030, USD Million
          4. Others (Sports Medicine Centers, Academic Institutes) – Market Size & Forecast 2025-2030, USD Million
        4. By Distribution Channel
          1. Direct Sales – Market Size & Forecast 2025-2030, USD Million
          2. Distributors/Wholesalers – Market Size & Forecast 2025-2030, USD Million
          3. Online Sales – Market Size & Forecast 2025-2030, USD Million
          4. Others – Market Size & Forecast 2025-2030, USD Million
        5. By Region
          1. North
          2. East
          3. South
          4. West
        6. Competition Outlook
          1. Company Revenue Shares
          2. Competitor Characteristics
  9. U.S. Arthroscopic Partial Meniscectomy Treatment Market Outlook, 2025-2030
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Procedures)
    2. Market Share & Outlook
      1. By Product Type– Market Size & Forecast 2025-2030, USD Million
      2. By Procedure– Market Size & Forecast 2025-2030, USD Million
      3. By End-User– Market Size & Forecast 2025-2030, USD Million
      4. By Distribution Channel– Market Size & Forecast 2025-2030, USD Million
  10. U.S. Meniscus Repair Treatment Market Outlook, 2025-2030
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Procedures)
    2. Market Share & Outlook
      1. By Product Type– Market Size & Forecast 2025-2030, USD Million
      2. By Procedure– Market Size & Forecast 2025-2030, USD Million
      3. By End-User– Market Size & Forecast 2025-2030, USD Million
      4. By Distribution Channel– Market Size & Forecast 2025-2030, USD Million
  11. U.S. Meniscus Transplantation Treatment Market Outlook, 2025-2030
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Procedures)
    2. Market Share & Outlook
      1. By Product Type– Market Size & Forecast 2025-2030, USD Million
      2. By Procedure– Market Size & Forecast 2025-2030, USD Million
      3. By End-User– Market Size & Forecast 2025-2030, USD Million
      4. By Distribution Channel– Market Size & Forecast 2025-2030, USD Million
  12. U.S. Meniscus Treatment Market Key Strategic Imperatives for Success & Growth
  13. Company Profiles
    1. Company Revenue Shares
    2. Competitor Characteristics
      1. Smith+Nephew plc
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Arthrex, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Stryker Corporation
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Zimmer Biomet Holdings, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Johnson & Johnson (DePuy Synthes)
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. ConMed Corporation
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Medtronic plc
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. RTI Surgical Holdings, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Bioventus Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Others
  14. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making